\[1\]CLSI. EP09-A2-IR. Method comparison and bias estimation using patient sample; approved guideline-second edition\[S\]. PA: Clinical and Laboratory Standards Institute, 2002.［2］NCCLS. EP15-A. User demonstration of performance for precision and accuracy; approved guideline \[S\]. Pennsylvania: USA, 2001.［3］NCCLS. EP6-A. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline\[S\]. Pennsylvania: USA, 2003.［4］NCCLS. EP17-A. Protocols for determination of limits of detection and limits of quantitation; approved guideline\[S\]. Pennsylvania: USA, 2004.［5］NCCLS. C28-A2. How to define and determine reference intervals in the clinical laboratory：second edition\[S\]. Pennsylvania:USA, 2000.［6］Zaska M, Szturmowicz M, Zych J, et al. Elevated serum NSE level in locally advanced and metastatic NSCLC predispose to better response to chemotherapy but worse survival\[J\]. Pneumonol Alergol Pol, 2010, 78(1):14-20.［7］许斌. 医院检验科建设管理规范\[M\]. 2版. 南京：东南大学出版社，2013：235.
2014, Vol. 24 
